Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography. - Wikidata - wikimedia - TriplyDB

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

http://www.wikidata.org/entity/Q35804873

about

Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Characteristics of Tau and Its Ligands in PET Imaging Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges Tau PET imaging: present and future directions.Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET study Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.Imaging tau pathology in Parkinsonisms.Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy.Cingulate island sign temporally changes in dementia with Lewy bodies.In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.Characterization of the radiosynthesis and purification of [18F]THK-5351, a PET ligand for neurofibrillary tau.A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.The Interactive Effects of Age and PICALM rs541458 Polymorphism on Cognitive Performance, Brain Structure, and Function in Non-demented Elderly.Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.The development and validation of tau PET tracers: current status and future directions Predict Disease Progression With Reaction Rate Equation Modeling of Multimodal MRI and PET

P2860

Q26749755-B1AA32F6-274E-4D01-8E9F-D7293FBD0CA1 Q26769952-9A1352CF-51DB-4880-91B1-0FB0A9FEA7AE Q26773443-475E9025-78F9-4149-9C4D-3E7F55D464E4 Q28072061-E8B5772D-159E-4416-8E5F-453A41B7EBE1 Q34680852-6FC7C949-C27B-4892-AD7A-C8FC006773E5 Q37294936-67CA5A44-A892-4C84-9376-36B9E67C794E Q37600680-BEA970B0-0B43-4855-AF20-83315A0615E4 Q37731919-4A5D1240-4943-49A1-BB53-B08A5DF1A1AD Q38979999-CD3E34F5-3A80-4818-9948-69E33D09DAC5 Q39016306-B54A5B8D-462F-46CB-A916-3243D3CF22D3 Q39419877-17A1E5AD-6639-439A-AEC2-118E3B5C7F14 Q42501180-FA998E85-A9DF-4F52-AC71-482C88049A7B Q43449932-E93100BF-B27E-4DC1-A0AA-A316298D73A2 Q47199611-A05EB9B7-1F6F-4E51-8284-964693D8C1B0 Q47739900-FA488DF9-2014-48D0-88B1-4FE9479193FC Q47833026-525ACEF9-B653-4B0B-9A6F-81B23DEC8EAB Q48162688-B7282CDC-01DE-418A-8F78-1E2D10349F93 Q48342993-2C3CB6C7-758F-4449-8D2C-DB2CFBF1158C Q50583370-FA0BCA54-EDCF-45A5-80C9-476FB40A8396 Q52609373-19749D16-939F-47B5-98F7-C3C52A28BA8F Q53398002-249C0715-6185-4E4D-A672-9AFB579D99D9 Q56594907-4B83F8DD-8974-40DA-9F10-8A70A65C4B54 Q57817391-1229170C-C418-4583-9953-EDB6F5673795

P2860

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

http://www.wikidata.org/entity/Q35804873

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@ast

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@en

type

label

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@ast

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@en

prefLabel

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@ast

Longitudinal Assessment of Tau ...... Positron Emission Tomography.

@en

P1433

Q35804873-40B5D3D6-8BC7-47D8-85B6-FE14D35D9CBA

P1476

Q35804873-83329FEE-AB6E-419E-950E-13DBF181AE8F

P2093

Q35804873-167C3578-9858-4D07-A428-6DF6659783CE

Q35804873-1EE5B1D8-BDDB-4F3A-973D-2BB5273997AB

Q35804873-2F437D3C-A887-47A2-8C0B-BA0343107DED

Q35804873-3C25F167-D323-43C8-9C77-47EC22F1B274

Q35804873-4223F0D0-CA02-4A01-B8A3-65BD51FE5EB6

Q35804873-8BB24FC3-8DBD-4F54-A1A8-82F7B4BD30B8

Q35804873-8EE3E57C-4D39-4509-B6B9-57C4432DC209

Q35804873-93A36D26-920D-4C93-8AC4-BCF6D7D2AE5A

Q35804873-991AB431-0046-4985-82FD-C059E8C3BDC5

Q35804873-B7870BA6-4794-4AD7-AA0D-6AFBE10C73F7

P2860

Q35804873-000F6E66-0961-4093-823F-8A5C3392C838

Q35804873-018B0230-DFBD-41BD-B7AD-44C7B57FD2F8

Q35804873-0494F597-F27A-4385-839A-86D9263144A7

Q35804873-04F3E323-A02A-4081-90AD-8022D7933236

Q35804873-11F138DB-A221-4731-BC3D-A9077342CBDB

Q35804873-145795E7-E5AE-43AF-81C4-97C530203DAF

Q35804873-25002514-B414-49B9-AB52-798D4543F14B

Q35804873-2E52C78C-75B6-449E-830D-66B867B17063

Q35804873-33BAA20E-5034-4CD1-9C33-1415EC02F7C1

Q35804873-4CECB974-0B82-4D52-B275-D72728CD93E1

P304

Q35804873-26762F66-8391-457E-A7FA-E783AA1500EF

P31

Q35804873-296F7F4C-49A4-431E-AF00-344755B3C6C5

P356

Q35804873-278C6FCC-1989-46FB-A73C-3A7B92A00379

P407

Q35804873-BABD43A8-2EE2-4D83-860E-253B68A89A92

P433

Q35804873-A81EE672-0CE6-4400-9BAB-C5769011C7AF

P478

Q35804873-A6A1AC02-BD6C-4190-A82F-C32AD71BF9D0

P50

Q35804873-149601A2-87B7-42F9-9DB2-B671E3B89D7D

Q35804873-85711035-EC74-4661-9C7B-208F9BB1B711

Q35804873-C0826320-23C2-4769-8796-57D425F0AC88

P577

Q35804873-DB6BCE10-0AA0-42E2-AC87-0A62EB3CAD45

P5875

Q35804873-B3EBE952-D231-4DEE-A327-E5EAB17CAB81

P698

Q35804873-43312E7B-49A0-479B-A165-8030C34E813D

P921

Q35804873-6A286597-B403-4CA0-8808-ECCA9644F379

P932

Q35804873-3BA583B6-DA1B-49AF-BD7D-9B11C514A54F

P356

JOURNAL.PONE.0140311

P1433

P1476

Longitudinal Assessment of Tau ...... 7 Positron Emission Tomography

@en

P2093

Aiko Ishiki

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Arai

http://www.w3.org/2001/XMLSchema#string

Katsutoshi Furukawa

http://www.w3.org/2001/XMLSchema#string

Kotaro Hiraoka

http://www.w3.org/2001/XMLSchema#string

Manabu Tashiro

http://www.w3.org/2001/XMLSchema#string

Naoki Tomita

http://www.w3.org/2001/XMLSchema#string

Ren Iwata

http://www.w3.org/2001/XMLSchema#string

Ryuichi Harada

http://www.w3.org/2001/XMLSchema#string

Shoichi Watanuki

http://www.w3.org/2001/XMLSchema#string

Shozo Furumoto

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

P304

e0140311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0140311

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Nobuyuki Okamura

P577

2015-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283242661

http://www.w3.org/2001/XMLSchema#string

P698

26461913

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4604169

http://www.w3.org/2001/XMLSchema#string